SCHEMBL15326622

SCHEMBL15326622

Cc1cccc(C(=O)Oc2nnnn2CCNS(=O)(=O)c2cccc3c(N(C)C)cccc23)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
HDAC5 Q9UQL6 1/20 0.44
HTR1A P08908 3/20 0.43
GLB1 P16278 1/20 0.41
PTGS2 P35354 2/20 0.41
FUCA1 P04066 1/20 0.41
EPHX2 P34913 1/20 0.41
GBA1 P04062 1/20 0.40
NPC1 O15118 1/20 0.40
TP53 P04637 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
TSHR P16473 1/20 0.40
CYP2C19 P33261 1/20 0.40
THPO P40225 1/20 0.40
MTOR P42345 1/20 0.40
RAB9A P51151 1/20 0.40
HIF1A Q16665 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15326554 0.91 HDAC4 (0.46) HDAC4HDAC10HDAC6HDAC5HTR1A
SCHEMBL16087856 0.88 EDNRA (0.46) HDAC4HDAC10HDAC6HDAC5HTR1A
SCHEMBL15326625 0.76 HDAC4 (0.44) HDAC4HDAC10HDAC6HDAC5HTR1A
SCHEMBL15326553 0.76 HDAC4 (0.46) HDAC4HDAC10HDAC6HDAC5HTR1A
SCHEMBL15326624 0.74 EDNRA (0.46) HDAC4HDAC10HDAC6HDAC5HTR1A
SCHEMBL15326619 0.73 KMT2A (0.45) HTR1ATSHR
SCHEMBL15326526 0.72 LMNA (0.42) HDAC4HDAC10HDAC6HDAC5HTR1A
SCHEMBL20097360 0.70 EDNRA (0.52) HDAC4HDAC10HDAC6HDAC5HTR1A
SCHEMBL12961987 0.68 EPHX2 (0.59) HDAC4HDAC10HDAC6HDAC5GLB1
SCHEMBL18131884 0.68 EPHX2 (0.64) HDAC4HDAC10HDAC6HDAC5GLB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8975288-B2 F2 derivatives as antibacterial agents THE PENN STATE RESEARCH FOUNDATION (US) 2015-03-10 US disclosed
US-8975288-B2 F2 derivatives as antibacterial agents THE PENN STATE RESEARCH FOUNDATION (US) 2015-03-10 US disclosed
US-20140275192-A1 F2 DERIVATIVES AS ANTIBACTERIAL AGENTS THE PENN STATE RESEARCH FOUNDATION 2014-09-18 US disclosed
US-20140275192-A1 F2 DERIVATIVES AS ANTIBACTERIAL AGENTS THE PENN STATE RESEARCH FOUNDATION 2014-09-18 US disclosed
WO-2013154793-A1 F2 DERIVATIVES AS ANTIBACTERIAL AGENTS THE PENN STATE RESEARCH FOUNDATION (US) 2013-10-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140275192-A1 F2 DERIVATIVES AS ANTIBACTERIAL AGENTS NR2C2, H1-10, NR2F2 HDAC4 991/4885HDAC10 24/4885HDAC6 1421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.